HFCAS OpenIR

浏览/检索结果: 共33条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe;  Zhang, Qingyuan;  Liberati, Anna Marina;  Cao, Junning;  Yang, Haiyan;  Hao, Siguo;  Hu, Jianda;  Zhou, Keshu;  Petrini, Mario;  Russo, Filomena;  Zhang, Huilai;  Sang, Wei;  Ji, Jie;  Ferreri, Andres Jose Maria;  Damaj, Gandhi Laurent;  Liu, Hui;  Zhang, Wei;  Ke, Xiaoyan;  Ghiggi, Chiara;  Huang, Sha;  Li, Xiaotong;  Yao, Hui;  Paik, Jason;  Noveotny, William;  Zhou, Wenxiao;  Zhu, Hongji;  Zinzani, Pier Luigi
收藏  |  浏览/下载:26/0  |  提交时间:2023/11/10
Magnetic properties and critical behavior of quasi-2D layered Cr4Te5 thin film 期刊论文
FRONTIERS OF PHYSICS, 2023, 卷号: 18
作者:  Liu, Hao;  Fan, Jiyu;  Zheng, Huan;  Wang, Jing;  Ma, Chunlan;  Wang, Haiyan;  Zhang, Lei;  Wang, Caixia;  Zhu, Yan;  Yang, Hao
收藏  |  浏览/下载:45/0  |  提交时间:2022/12/23
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 卷号: 15
作者:  Liu, Long;  Yu, Xingxing;  Li, Zhifeng;  He, Xiaohua;  Zha, Jie;  Lin, Zhijuan;  Hong, Yan;  Zheng, Huijian;  Lai, Qian;  Ding, Kaiyang;  Jia, Xian;  Fu, Guo;  Yu, Haifeng;  Yang, Haiyan;  Li, Zhiming;  Young, Ken H.;  Xu, Bing
收藏  |  浏览/下载:30/0  |  提交时间:2022/12/23
FL  TIME  POD  Immune signature  T cells  
Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe;  Zhang, Qingyuan;  Liberati, Anna Marina;  Cao, Junning;  Yang, Haiyan;  Hao, Siguo;  Hu, Jianda;  Zhou, Keshu;  Russo, Filomena;  Zhang, Huilai;  Sang, Wei;  Ji, Jie;  Liu, Hui;  Huang, Sha;  Zinzani, Pier Luigi
收藏  |  浏览/下载:33/0  |  提交时间:2022/12/23
The Prognostic Utility of F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Li, Cong;  Yu, Haifeng;  Chen, Xi;  Han, Shuiyun;  Peng, Shuailing;  Lei, Tao;  Yang, Haiyan
收藏  |  浏览/下载:28/0  |  提交时间:2022/12/23
diffuse large B cell lymphoma (DLBCL)  interim 18 F-FDG PET  prognosis  RCHOP  treatment response  
Design, synthesis and biological evaluation of sulfonamides inhibitors of XPO1 displaying activity against multiple myeloma cells 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 235
作者:  Qu, Bingxue;  Xu, Yongjin;  Lu, Yang;  Zhuang, Weihao;  Jin, Xinxin;  Shi, Qiuqiu;  Yan, Shike;  Guo, Yu;  Shen, Zheyuan;  Che, Jinxin;  Wu, Yize;  Tong, Lexian;  Dong, Xiaowu;  Yang, Haiyan
收藏  |  浏览/下载:25/0  |  提交时间:2022/12/23
XPO1  Multiple myeloma  MM.1S  N-phenylsulfonamide  Oral administration  
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan;  Lizaso, Analyn;  Xu, Chunwei;  Liu, Jun;  Wang, Wenxian;  Song, Zhengbo;  Ou, Sai-Hong Ignatius;  Yang, Nong
收藏  |  浏览/下载:46/0  |  提交时间:2022/05/05
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili;  Zou, Dehui;  Lv, Fangfang;  Guo, Wei;  Liu, Aichun;  Li, Caixia;  Tan, Ziwen;  Liu, Yang;  Fu, Lina;  Guo, Haiyi;  Novotny, William;  Huang, Jane;  Li, Yufu
收藏  |  浏览/下载:34/0  |  提交时间:2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng;  Zou, Dehui;  Li, Wei;  Yang, Haiyan;  Liu, Ting;  Wang, Quanshun;  Lv, Fangfang;  Guo, Haiyi;  Zhao, Xia;  Wang, Dan;  Zhang, Pei;  Wang, Yidi;  Wang, Lei;  Liu, Tengfei;  Zhang, Yun;  Shen, Zhirong;  Huang, Jane;  Zhu, Jun
收藏  |  浏览/下载:44/0  |  提交时间:2022/05/05
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao;  Yu, Haifeng;  Guo, Na;  Li, Cong;  Peng, Shuailing;  Dong, Xiaowu;  Yang, Haiyan;  Wu, Meijuan
收藏  |  浏览/下载:55/0  |  提交时间:2022/02/14
Hodgkin lymphoma  PD-1 inhibitor  PD-L1 inhibitor  PD-L2  Molecular phenotype  Tumor microenvironment